GABRIELLA CARRIZALES: Open Payments
NPI 1902445885 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,079 in 82 payments from 15 companies in 2025. Trend: 2023 $342 · 2024 $676 · 2025 $2,079
Food & beverage: $2,012Education: $67
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 21 | $732 |
| UCB, Inc. | 11 | $261 |
| Lilly USA, LLC | 5 | $221 |
| Regeneron Healthcare Solutions, Inc. | 9 | $150 |
| ABBVIE INC. | 9 | $148 |
| Janssen Biotech, Inc. | 3 | $101 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $98 |
| LEO Pharma Inc. | 4 | $85 |
| PFIZER INC. | 3 | $59 |
| Organon LLC | 3 | $51 |
Products named: NEMLUVIO, Bimzelx, DUPIXENT, EBGLYSS, SKYRIZI, TALTZ, TREMFYA, ILUMYA.
Industry payments across TX — which companies pay providers there.
